Page 2 - Sun Pharmaceutical Industries Ltd News

Sun Pharma Q1 profit rises 27% to ₹2,895 crore as revenue grows over 10%

Revenue from operations grew 10.5 per cent to ₹15,299.88 crore, while EBITDA margin narrowed by 220 basis points to 28.9 per cent as India sales rose 16 per cent

Stocks to Watch today: Tata Steel, ITC, Sun Pharma, Swiggy, IOCL, IRFC

Stocks to watch today: Tata Steel, Tata Power, ITC, Sun Pharma, Swiggy, IOCL, IRFC, Maruti Suzuki, Bajaj Finance, JBM Auto, LIC Housing Finance, Hyundai Motor, among others, will be in focus today

Sun Pharma, TVS Motor, Nestle, Divis among 11 BSE 500 stocks at new highs

Among others, Manappuram Finance, Marico, Radico Khaitan, Redington, Welspun Corp, Laurus Labs and Sai Life Sciences also touched respective all-time highs in trade on Thursday.

Sun Pharma to launch semaglutide in Brazil with Hypera Pharma soon

Sun Pharma will launch the once-weekly diabetes treatment through Hypera Pharma as generic competition intensifies in Brazil's $413 million semaglutide market

Sun Pharma Q1 preview: Robust domestic growth to drive revenue by 11% Y-o-Y

Brokerages see an 11 per cent topline growth in Q1 FY27. HDFC Securities said that the US generic business will be muted due to the absence of gRevlimid, while the India business may grow 13 per cent.

Sun Pharma: Bajaj Broking recommends 'Buy'; flags 4 positive cues on charts

Sun Pharma outlook: Analysts at Bajaj Broking flag a breakout above the monthly consolidation zone and the formation of higher-highs, higher-lows among key reasons for a bullish view on the stock.

The reform booster shot that transformed India into pharmacy of the world

From generics to global leadership, India's pharmaceutical industry has transformed since 1991. Its next challenge is becoming a global hub for breakthrough drug innovation

Glenmark, Biocon, Aurobindo slip 3% on Trump's generic drug tariff plan

The US President Donald Trump announced a proposal to impose phased tariff (up to 200%) regime on imported generic medicines aimed at encouraging pharmaceutical manufacturing within the United States.

Pharma index surges 2%; Torrent, Mankind, Cipla, Aurobindo soar up to 5%

Pharma stocks: RPG Life, Thyrocare, Hester Biosciences, Rubicon Research, IOL Chemicals, Emcure and Suven Life from the BSE Healthcare index rallied between 4% and 8% on Monday.

Sun Pharma gets South Africa approval for generic semaglutide, launch soon

Sun Pharma has secured South Africa's approval for its generic semaglutide injection and plans to launch the once-weekly diabetes treatment in the coming days

Sun Pharma receives approval to launch generic semaglutide in South Africa

The approval makes South Africa the second market after India where the drugmaker has secured regulatory clearance for its generic version of semaglutide

Ajit Mishra recommends buy on Aether Energy, Sun Pharma; sell on ITC

Ajit Mishra of Religare Broking says that Ather Energy and Sun Pharma have a given a upside breakout after a period of consolidation, while ITC seems to be losing momentum on charts.

Pharma stocks: Lupin, Torrent hit new peaks; Sun nears summit; here's why

Pharma stock rally: Orchid Pharma, Hikal, Unichem Labs, IOL Chemicals, SPARC, RPG Life Sciences and Acutaas Chemicals surged up to 13% in Wednesday's trade.

Stocks to Watch today: Maruti, RCF, BHEL, Torrent Pharma, Tata Power, IHCL

Stocks to watch today: Maruti Suzuki, Uno Minda, BHEL, Torrent Pharma, Tata Power, IHCL, IDFC First Bank, Kalyan Jewellers, Premier Energies, RCF, RRP Defense, among others, will be in focus today

SBI joins global banks to fund Sun Pharma's $11.75 billion Organon buy

SBI is the only domestic bank to participate in the loan syndication

Nifty Pharma rallies 2%; Laurus, Ipca, Aurobindo, Torrent hit record highs

In the past month, the Nifty Pharma index outperformed the market by surging 7.4 per cent, as compared to 4.2 per cent rise in the Nifty 50.

Dividend stocks: Mphasis, Titan, Nestle, 41 others go ex-date next week

Dividend stocks: Here is the complete list of stocks that will remain in focus next week on account of their dividend announcements

Nifty Pharma index up 2%; Dr Reddy's, Ajanta, Ipca, Cipla surge up to 5%

In the past seven trading days, the Nifty Pharma index outperformed the market by soaring 5.4 per cent, as compared to 0.1 per cent decline in the Nifty 50.

Sun Pharma to acquire 100% stake in Innovcare Lifesciences for $28.7 mn

Sun ​Pharmaceutical Industries said ‌it will acquire 100% of ​Innovcare Lifesciences

Patent expiry: A $5 bn opportunity for Indian pharma majors, says report

Lupin, Intas Pharmaceuticals, Sun Pharma, MSN Laboratories, Natco Pharma, Zydus Life Sciences and Dr Reddy's Laboratories are some of the companies, the note said, that could potentially benefit.